4B Technologies Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 11

4B Technologies General Information

Description

Manufacturer of neurological disorder medicines designed to slow down or halt disease progression. The company utilises allosteric modulation and humanised monoclonal antibodies, providing pharmaceutical companies and healthcare providers with neurological disorder medicines, central nervous system therapeutics, neurodegenerative disease treatments, non-opioid pain therapies, investigational monoclonal antibodies, and transformative medicines to achieve analgesic effects without the side effects of broad nerve growth factor pathway disruptions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 2106, 2nd Floor, Building D, Number 33
  • Number 99, Kechuang 14th Street, Beijing Economic-Technological Development Area
  • Beijing, 100176
  • China
+86 010
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • Room 2106, 2nd Floor, Building D, Number 33
  • Number 99, Kechuang 14th Street, Beijing Economic-Technological Development Area
  • Beijing, 100176
  • China
+86 010

4B Technologies Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

4B Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 01-Feb-2025 Completed Generating Revenue
3. Later Stage VC 12-Dec-2022 Completed Generating Revenue
2. Early Stage VC (Series A2) 09-Feb-2021 $25M Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jan-2020 Completed Generating Revenue
To view 4B Technologies’s complete valuation and funding history, request access »

4B Technologies Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Beijing Fangsheng Investment Management Center Growth/Expansion Minority
Beijing Zhongguancun Collaborative Innovation Investment Fund Management Corporate Venture Capital Minority
Daoyuan Capital Venture Capital Minority
Fortune Capital Venture Capital Minority
Zhuhai China Thrive Fund Management Growth/Expansion Minority
You’re viewing 5 of 11 investors. Get the full list »

4B Technologies FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process